PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
298.1K views | +1 today
Follow

The Untold Story of Biotech and Pharma #esante #hcsmeufr

From demy-colton.com

The last 20 years have witnessed a seismic change in the biotech industry - and the world. Not only has the rapid growth of science and technological advances changed what is possible in the business of biotechnology, but so too have business models and investment acumen. The entire space has experienced growth and maturity that newer entrants wouldn’t believe. Those of us who have lived, as well as instigated, the evolution couldn’t be prouder of the biotech industry and the key players who have facilitated the changes that make the future possible. Today it is hard to believe that 20 years ago there was no such thing as transparency between pharma and biotech, and to be honest, it was because pharma was comfortable with their pipelines and didn’t want much to do with the untested and mostly unproven brave new world that was biotechnology.
No comment yet.

Conversations with Greg Freiherr: The Accuray Philosophy  #hcsmeufr #esante

From www.itnonline.com

Accuray's philosophy is to personalize treatments to exactly fit the patient. Senior Director of Marketing Andrew Delao explains this philosophy in a conversation with Greg Freiherr at ASTRO 2018.
No comment yet.

Pharma marketing trends 2019: what to expect and how to evolve

From viseven.com

As 2018 has almost gone by, new tech trends and breakthroughs lie further to embrace. Let’s unveil some upcoming trends pharma marketers should stay up-to-date with.
No comment yet.

Roche launches two lab management apps under its Viewics platform #esante #hcsmeufr

From www.fiercebiotech.com

Roche has launched new two software apps that aim to optimize the financial and clinical effectiveness of diagnostics laboratories and hospitals—its first under the Viewics cloud-based analytics platform that it acquired late last year.

The LabOPS program offers real-time monitoring of laboratory performance, with the goal of producing a data-driven continuous improvement process. It keeps track of metrics such as test volumes, turn-around-time, backlog and quality control, while alerting staff of possible issues in meeting service agreements.

It can also help administrators reduce waste and improve operational and financial processes, Roche said. LabOPS is available internationally in English, French, German, Spanish and Brazilian Portuguese.

The second program, Dx Optimization, is a customizable solution that focuses on streamlining institutional clinical decision-making.

With about 5% of tests coming back outside of normal ranges and requiring additional testing, according to Viewics, Dx Optimization allows for retrospective assessments of inappropriately ordered tests, which can raise costs and use up resources. It is available in English for the U.S. and Canada.

No comment yet.

How Data Visualization Is Transforming the Health Industry #esante #hcsmeufr

From killerinfographics.com

Data visualizations make complex information easier to analyze and assess than ever. Here's how data visualization is revolutionizing the health industry.
No comment yet.

Why Big Data is Critical to the Pharmaceutical Industry #esante #hcsmeufr

From insidebigdata.com

In this special guest feature, Inga Shugalo, a Healthcare Industry Analyst at Itransition, suggests that whether it’s an application for precision medicine, decreasing the failure rates in drug trials, or lowering the cost of research and developing better medicine, big data has a bright future for the pharmaceutical industry.
No comment yet.

Qui a peur du grand méchan …gement ? #esante #hcsmeufr 

From curiouser.fr

Curiouser était présent le 8 novembre dernier au forum Innowvations organisé par l’agence Zcomme. Retour sur la prise de parole de Cyril autour du « grand méchan…gement ». Il n’y a pas si longtemps, dans un arrondissement Lire la suite…
No comment yet.

Digital strategy: The four fights companies need to win | McKinsey  #esante #hcsmeufr #digitalhealth

From www.mckinsey.com

Successful companies need clarity about the demands of digital technologies, strong leadership, agility and bold investments.
No comment yet.

Visualizing the Most Innovative Companies in 2018  #pharma #esante #hcsmeufr #digitalhealth

From howmuch.net

The largest companies in the world have massive R&D budgets, but not everyone is investing in innovation at the same rate. Our visualization breaks down the top 50 leaders by industry category.
No comment yet.

Boehringer Ingelheim crée à Lyon le premier accélérateur de santé digitale  #esante #hcsmeufr #digitalhealth

From connected-vet.com

En collaboration avec 1Kubator, le premier réseau d’incubateurs de France, Boehringer Ingelheim annonce la création du premier accélérateur de santé digitale.Ce programme dédié aux start-up e-santé sera implanté au sein de l’immeuble Boreal, dans le Biodistrict de Lyon-Gerland, siège des activités de santé animale du groupe allemand.  Les trois premières start-up retenues seront accompagnées dès janvier …
No comment yet.

Survey: Most health informatics executives see ‘big tech’ as a threat | FierceHealthcare  #esante #hcsmeufr #digitalhealth

From www.fiercehealthcare.com

Seven in 10 health IT executives are “somewhat concerned” about technology companies like Google, Amazon and Apple encroaching into the healthcare space. Many see the consumer tech giants pushing health systems toward price transparency faster than they want to go.
No comment yet.

Transformation numérique : de la culture des pyramides à celle des pancakes #Esante #Hcsmeufr 

From www.itespresso.fr

Une étude académique entérine le management horizontal comme l'un des marqueurs de la transformation numérique des entreprises.
No comment yet.

Les industriels de #santé face au casse-tête du #recrutement des profils #tech #RH #hcsmeufr 

From www.ticpharma.com

Avec la digitalisation croissante de la santé, les industriels du secteur sont à la recherche de nouveaux profils de data scientists, développeurs ou managers capables d'encadrer des équipes techniques, et doivent revoir en profondeur leurs processus de recrutement, ont témoigné auprès de TICpharma les cabinets de recrutement GenSearch et Mobiskill, respectivement spécialisés dans les sciences de la vie et les nouvelles technologies.
GIE_GERS's curator insight, November 26, 1:57 AM

Avec la digitalisation croissante de la santé, les industriels du secteur sont à la recherche de nouveaux profils de data scientists, développeurs ou managers capables d'encadrer des équipes techniques, et doivent revoir en profondeur leurs processus de recrutement, ont témoigné auprès de TICpharma les cabinets de recrutement GenSearch et Mobiskill, respectivement spécialisés dans les sciences de la vie et les nouvelles technologies.

Pharmaceutical Case Study: How Sanofi got 400% engagement rate

From thinkmarketingmagazine.com

Establishing a pharmaceutical brand is hard enough with the over-saturated nature of the industry, brands also have to push against the ever-growing tide of brands online. The battle for eyeballs and attention is fierce, for any industry. Balancing between being part of a serious industry and engaging social media users is tough for pharmaceutical products. Finding that inner balance is French pharmaceutical company, Sanofi, whose social media accounts are an example of how social media and big Pharma can exist. We look at 3 of their OTC products social media accounts (Maalox, Novaldol, Telfast) and their health awareness campaign, Sanofi Diabetes, who have been able to keep fans quite engaged this past year.   Keeping it Light-Hearted Sanofi and their digital agency, Eureka, have been keeping it a bit more comedic with two of their main pages. Maalox and Novaldol have been leading the pack with their own separate brand of light and sarcastic captions. Maalox and Novaldol are leading products in their respective categories, with a solid engagement strategy.   When Maalox talks, it talks Comedy At 269K fans, this antacid medicine has been focused on relatable posts with a tinge of comedy. The Facebook page’s engagement rate between Nov. 2017 and 2018 is 86.3%, with an average 2.97% per post. Do you remember their ad from Ramadan this year?   Pain-killing Sarcasm Their pain-killer, Novaldol, leans more into our favorite engagement theme, Sarcasm. Using this focus, the brand has been able to grab a 121.2% Facebook page engagement rate, with an 8.6% per post. They play with simple elements to emphasize the headaches around us. The brand also has a small snarky side, subtlety making fun of their competition with a short-animated video.   Back to Good Ol’ Advice Giving Sanofi’s other half is all about being the doctor or advice giver, starting with Telfast. With this antihistamine over the counter med, the pharmaceutical company leans towards a more consumer-centered informatic social style. Throughout the page, you can find examples of the style where the brand talks about protecting yourself from dirt/sand storms, causes of allergies, symptoms and more. The brand must be doing something right, with their Facebook page handling an engagement rate of 421.46% between Nov. 2017 and 2018, alongside 6.58% engagement per post. The thing about this post is not just its informatic nature, it’s about its timing, noting that there was a storm at that time. Finally, Sanofi’s diabetes awareness campaign which aims to provide diabetic patients and their caregivers with all the needed information and advice on how to control diabetes properly and avoid its complications, living the healthy life they deserve. The engagement rate for the page is at a whopping 1213.55%, with around 15.76% engagement per post. Big Pharma on Social Sanofi’s work shows us that although sarcasm usually leads in many other industries, going the safe and informatic route is the way to go for pharmaceutical companies. Among the mentioned OTC accounts, Telfast has the highest engagement rate per page, although Novaldol’s engagement rate per post is the highest of them all. Of all the posts on all 4 accounts, Novaldol again steals the show with this post.   The post boasts 72.5K likes. Sanofi’s digital agency of 3 years, Eureka, has been providing the guiding hand for the brand’s great social media community building. Eureka is a vibrant digital agency founded in England, operating from their offices in Cairo and Dubai, delivering all in digital marketing aspects, while maintaining their startup spirit. Their success comes from gathering a powerful team of creatives and designers backed by a very solid team of medical social media specialists. You can find them here.
No comment yet.

Pharma companies put faith in AI for breakthrough discoveries  #esante #hcsmeufr

From www.ft.com

Billions are being bet to find the next revolutionary drug. US start-up Berg was asked by the Department of Defense to help improve the detection of prostate cancer, a disease common among pilots. Less than five years later, an artificial intelligence-driven tool has been tested on more than 1,000 patients with promising results.

 

Excitement about AI, machine learning and big data have prompted a boom in health-tech start-ups in a market traditionally dominated by big pharma. Despite debate over the extent to which AI will revolutionize medical science, billions are being bet on something revolutionary emerging to drive the next big leaps in drug development This year has seen a jump in investment from big pharma and a range of joint ventures with health tech groups.

 

In 2018, at least 15 companies have integrated AI into their drug discovery processes, according to Deep Knowledge Analytics, an analysis company. “We’ve seen huge interest from many of the major pharma companies” in the past 18 months, says Andrew Hopkins, chief executive of Exscientia, an AI-driven drug discovery company working with GlaxoSmithKline. Other partnerships include AstraZeneca’s and Sanofi’s projects with Berg, and Merck’s work with Numerate, another drug design company. In-house developments include Pfizer using AI to mine patient data — stored anonymously in electronic medical records — for signs of a rare form of heart failure. Novartis hopes a drug part-developed with AI will be registered within the next 36 months. “We see ourselves shifting from the mindset of a traditional pharma company to [one] more inherently agile, typical of a tech company,” says Badhri Srinivasan, Novartis’s head of global development operations.

 

About $5bn was invested in AI companies in 2016, according to consultancy IP Pragmatics, with healthcare one of the fastest growing sectors. By 2021, the value of the segment is expected to reach $6.6bn, with particular growth in China.

No comment yet.

La Transformation Digitale Est Celle De La Donnée Partagée #Esante #Hcsmeufr 

From www.forbes.fr

L’histoire est ponctuée de transformations consécutives à des disruptions technologiques. Les entreprises (en tout cas celles qui ont survécu !) ont de En quoi la transformation digitale actuelle diffère-t-elle des autres transformations technologiques ?
No comment yet.

Le CHU de Toulouse accompagné par l'Etat pour diffuser l'intelligence artificielle à l'#hôpital #IA #esante #hcsmeufr  

From www.ticsante.com

Le CHU de Toulouse fait partie des six lauréats d'un appel à manifestation d'intérêt mené dans le cadre du programme d'investissements d'avenir (PIA) afin d'accompagner des acteurs publics dans le déploiement d'outils d'intelligence artificielle (IA), dévoilés le 21 novembre par le secrétaire d'Etat chargé du numérique, Mounir Mahjoubi.
GIE_GERS's curator insight, November 26, 1:54 AM

Le CHU de Toulouse fait partie des six lauréats d'un appel à manifestation d'intérêt mené dans le cadre du programme d'investissements d'avenir (PIA) afin d'accompagner des acteurs publics dans le déploiement d'outils d'intelligence artificielle (IA), dévoilés le 21 novembre par le secrétaire d'Etat chargé du numérique, Mounir Mahjoubi.

Patient social media influencers are new frontier in pharma advertising  #esante #hcsmeufr

From www.beckershospitalreview.com

Drug companies have been using social media influencers to promote products, and for years Boston-based Wego Health has acted as the middleman, bringing pharmaceutical companies and influencers together, according to STAT.

Here are five things to know:

1. Social media influencers are people,  in this case patients, who have a following on social media apps and receive payment to promote specific material, a new frontier for the drug industry and drug advertising. Wego Health is one such company that acts as a "patient influencer talent agency," according to STAT.

"What has become obvious now is that micro-influencers, folks with smaller communities can have a dramatic impact on people’s behavior," Jack Barrette, founder and CEO of Wego Health, told STAT.

2. Patients who think they have a dedicated following and want to work with brands reach out to Wego's website, where Wego matches patient influencers with drug companies.

3. Patient influencers are paid both for creating posts about a drug or device and for bringing their followers' opinions to the company developing products. Drug developers pay Wego to reach out to its influencer network to promote new products. A drug company's return-on-investment is rather high while using influencers, due to their work costing less than other forms of direct-to-consumer advertising like TV advertisement.

4. From using social media influences alone, Wego Health's revenue grew to over $3 million in 2017.

An influencer endorsing an FDA-approved drug will be sent  information about the drug's risks that must be disclosed. When Kim Kardashian West did not mention the risks of a drug she promoted  for morning sickness in 2015, the FDA sent the company a warning letter and asked Ms. Kardashian West to remove her content.

5. STAT confirmed with the  FDA that there are no restrictions on  who can serve as a spokesperson for a prescription drug. Wego provides its influencers with educational programs on specific issues to cover, disclaimers they need to attach and teaches them how to doublecheck their claims using online material.

"We’re definitely advising them on how to stay on the right side of that line, but day-to-day we’re not kind of looking at folks and saying, are you crossing it or not," Mr. Barrette told STAT.

No comment yet.

A price comparison of recently launched proprietary pharmaceuticals in the UK and the US  #esante #hcsmeufr

From www.ncbi.nlm.nih.gov

To explore the relationship between prices charged by manufacturers of proprietary pharmaceuticals in the US and in the UK in recent years (2013–2016), expressed as a multiplier, and to detail to what extent this relationship differs for high-cost ...
No comment yet.

Five technologies that could disrupt pharma manufacturing #Esante #Hcsmeufr #digitalhealth

From www.in-pharmatechnologist.com

Pharma production is ‘too conservative’ and needs to ‘be bolder’ in adopting nascent technologies, or be left behind by new models, suggested one MD.
No comment yet.